Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 252
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots Phase 3
Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate
Review: Colorado Psychedelic Cup 2025
Dr Ros Watts – Building Communities and Connection
The Psychedelic News Feed: October 27 – November 02, 2025
PT244 – Mark Haberstroh – Mushrooms, Retreat Centers, and Safety
Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update
More than 80% of Americans report one or more symptoms of...
The Impact of Specific Genes on Cannabis Use Disorder
IntelGenx Announces Initial Closing of atai Investment
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop...
Bright Minds Biosciences Shares to Commence Trading on the OTCQB Venture...
Algernon Pharmaceuticals Receives Positive Feedback from U.S. FDA for Psychedelic Drug...
PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of...
MindMed Receives FDA Type C Meeting Response for Project Lucy Phase...
1
...
251
252
253
...
301
Page 252 of 301
